Couverture de Cov-idiots

Cov-idiots

Cov-idiots

Écouter gratuitement

Voir les détails

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

Listen to hosts Samantha Spiers and Wildcard Cameron discuss coronavirus stories that wouldn't fit in our last episode! Discussion includes an NIH study about COVID-19 prevalence in the summer, the fight over masks in schools, and actual social media posts from health agencies combating misinformation.

    

Post production by Scott Stronach.   


Check out other Sample Size episodes here and reach out to us on twitter or email us at samplesizeshow.gmail.com if you have any topics you want us to cover in the future!


Remember to get vaccinated against COVID-19 if you can and stay safe! Also consider donating to Imagine Water Works to provide relief from Hurricane Ida.


Sources: 

https://www.nih.gov/news-events/news-releases/nih-study-suggests-covid-19-prevalence-far-exceeded-early-pandemic-cases 

https://apnews.com/article/health-education-coronavirus-pandemic-school-boards-35db5c9eec87b85ca8eb95a64c2f6dd7 

https://www.nbcnews.com/news/us-news/florida-judge-orders-immediate-lifting-desantis-ban-school-mask-mandates-n1278720 

https://www.nbcnews.com/news/us-news/2-more-florida-school-districts-defy-desantis-order-vote-mask-n1277117 

https://www.forbes.com/sites/joewalsh/2021/09/10/appeals-court-reinstates-gov-desantis-ban-on-mask-mandates-in-florida-schools/?sh=46d030bf4aed 

https://twitter.com/US_FDA/status/1429050070243192839?s=19

https://www.theguardian.com/us-news/2021/aug/23/fda-horse-message-ivermectin-covid-coronavirus

https://twitter.com/CDCgov/status/1437842755196268555?s=19 

 

Support this show http://supporter.acast.com/sample-size.


Hosted on Acast. See acast.com/privacy for more information.

Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Aucun commentaire pour le moment